Drug-eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery
Qian Zhan,1 Baiyong Shen,1 Xiaxing Deng,1 Hao Chen,1 Jiabin Jin,1 Xing Zhang,2 Chenghong Peng,1 Hongwei Li1 1Department of General Surgery, Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China; 2Department of Surgery, University of Chicago...
Guardado en:
Autores principales: | Zhan Q, Shen B, Deng X, Chen H, Jin J, Zhang X, Peng C, Li H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e389e36ef44745c0af6240f6dfd93dbe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
por: Josep Gomez‐Lara, et al.
Publicado: (2021) -
Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents
por: Erik Pierstorff, et al.
Publicado: (2008) -
Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells
por: Xia W, et al.
Publicado: (2012) -
Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold
por: Stefan Toggweiler, et al.
Publicado: (2021) -
Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds
por: Tan Q, et al.
Publicado: (2011)